METTL3-mediated m6A modification of has_circ_0007905 promotes age-related cataract progression through miR-6749-3p/EIF4EBP1

被引:10
|
作者
Li, Rui [1 ]
Zhu, Haohao [2 ]
Li, Qian [1 ]
Tang, Jiancen [1 ]
Jin, Yiping [2 ]
Cui, Hongping [1 ]
机构
[1] Tongji Univ, Shanghai East Hosp, Sch Med, Dept Ophthalmol, Shanghai, Peoples R China
[2] Fudan Univ, Peoples Hosp Shanghai 5, Dept Ophthalmol, Shanghai, Peoples R China
来源
PEERJ | 2023年 / 11卷
基金
中国国家自然科学基金;
关键词
Age-related cataract; METTL3; has_circ_0007905; miR-6749-3p; EIF4EBP1; m6A modification; LENS EPITHELIAL-CELLS; DNA METHYLATION; APOPTOSIS; METTL3;
D O I
10.7717/peerj.14863
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Many cases of blindness are caused by age-related cataracts (ARCs). N6-methyladenosine (m6A)-modified circRNA widely participates in disease progression. However, the role of m6A modification of circRNA in ARC is unclear. We mined and elucidated the functions and mechanisms of key circRNAs with m6A modification involved in ARC progression. The GSE153722 dataset was used to mine m6A-mediated key circRNA. Loss-of-function assays and rescue assays were used to explore the effect and mechanism of circRNA on ARC cell proliferation and apoptosis. Has_circ_0007905 was a hypermethylated and upregulated expression in the ARC group relative to the control group both in vivo and in vitro. Silencing of has_circ_0007905 promoted proliferation and inhibited the apoptosis of HLE-B3 cells. METTL3 was upregulated in HLE-B3 cells after ARC modeling and had four binding sites with has_circ_0007905 and a mediated m6A modification of has_circ_0007905. Proliferation was significantly inhibited and apoptosis of HLE-B3 cells was facilitated by METTL3 overexpression, whereas these effects were prevented by has_circ_0007905 silencing. Silencing of has_circ_0007905 led to an alteration in the transcriptome landscape. Differentially expressed genes were mainly involved in immune-related processes and pathways. EIF4EBP1 overexpression promoted apoptosis and suppressed proliferation, and also significantly reversed effects of has_circ_0007905 silencing. Moreover, miR-6749-3p significantly decreased the luciferase activities of wild type plasmids with both of has_circ_0007905 and EIF4EBP1. MiR-6749-3p inhibitor blocked elevation in prolifer-ation and reduced EIF4EBP1 expression and apoptosis conferred by has_circ_0007905 silencing. We reveal for the first time that the commitment of ARC progression is guided by METTL3/has_circ_0007905/miR-6749-3p/EIF4EBP1 axis, and the results provide new insights into ARC pathology.
引用
收藏
页数:22
相关论文
共 50 条
  • [1] METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance
    Wang, Qiang
    Chen, Chen
    Ding, Qingqing
    Zhao, Yan
    Wang, Zhangding
    Chen, Junjie
    Jiang, Zerun
    Zhang, Yan
    Xu, Guifang
    Zhang, Jingjing
    Zhou, Jianwei
    Sun, Beicheng
    Zou, Xiaoping
    Wang, Shouyu
    GUT, 2020, 69 (07) : 1193 - 1205
  • [2] METTL3-mediated m6A modification of CDCA7 mRNA promotes COAD progression
    Hua, Mei
    Zhai, Xiaolu
    Chen, Ying
    Yin, Dian
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 260
  • [3] METTL3-mediated m6A modification promotes tumor progression in upper tract urothelial carcinoma
    Lin, Li-Jie
    Peng, Pei-Hua
    Hsu, Kai-Wen
    CANCER RESEARCH, 2024, 84 (06)
  • [4] METTL3-mediated m6A Modification of SRPK1 Promotes Lung Adenocarcinoma through Aerobic Glycolysis
    Wang, A.
    Zeng, Y.
    Zhang, W.
    Zhao, J.
    Gao, L.
    Li, J.
    Zhu, J.
    Liu, Z.
    Huang, J-A.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S189 - S190
  • [5] METTL3-mediated m6A modification of pri-miR-148a-3p affects prostate cancer progression by regulating TXNIP
    Li, Guoqiang
    Liu, Junwen
    Wang, Yinhuai
    Liu, Hanqi
    Fu, Jianhan
    Zhao, Yuanqiao
    Huang, Yanqing
    ENVIRONMENTAL TOXICOLOGY, 2023, 38 (10) : 2377 - 2390
  • [6] DCLRE1B promotes tumor progression and predicts immunotherapy response through METTL3-mediated m6A modification in pancreatic cancer
    Lincheng Li
    Fei Wang
    Zhaoda Deng
    Gong Zhang
    Lin Zhu
    Zhiming Zhao
    Rong Liu
    BMC Cancer, 23
  • [7] DCLRE1B promotes tumor progression and predicts immunotherapy response through METTL3-mediated m6A modification in pancreatic cancer
    Li, Lincheng
    Wang, Fei
    Deng, Zhaoda
    Zhang, Gong
    Zhu, Lin
    Zhao, Zhiming
    Liu, Rong
    BMC CANCER, 2023, 23 (01)
  • [8] METTL3-mediated m6A mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway
    Han, Hui
    Yang, Chunlong
    Zhang, Shuishen
    Cheng, Maosheng
    Guo, Siyao
    Zhu, Yan
    Ma, Jieyi
    Liang, Yu
    Wang, Lu
    Zheng, Siyi
    Wang, Zhaoyu
    Chen, Demeng
    Jiang, Yi-Zhou
    Lin, Shuibin
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2021, 26 : 333 - 346
  • [9] METTL3-mediated m6A modification of circGLIS3 promotes prostate cancer progression and represents a potential target for ARSI therapy
    Cheng, Xiaofeng
    Yang, Heng
    Chen, Yujun
    Zeng, Zhenhao
    Liu, Yifu
    Zhou, Xiaochen
    Zhang, Cheng
    Xie, An
    Wang, Gongxian
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2024, 29 (01)
  • [10] METTL3-mediated m6A modification of KIF3C-mRNA promotes prostate cancer progression and is negatively regulated by miR-320d
    Ma, Honggui
    Zhang, Facai
    Zhong, Quliang
    Hou, Jianquan
    AGING-US, 2021, 13 (18): : 22332 - 22344